234 related articles for article (PubMed ID: 12876872)
1. [Primary cytomegalovirus infection after combined cadaveric transplantation of the liver and kidney].
Slavicek J; Puretić Z; Glavas-Boras S; Smalcelj R; Barisić I; Vuković J; Seso-Simić D; Slavicek V; Humar I; Kes P
Acta Med Croatica; 2003; 57(1):87-90. PubMed ID: 12876872
[TBL] [Abstract][Full Text] [Related]
2. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
Boucher A; Lord H; Collette S; Morin M; Dandavino R
Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection in renal transplant recipients.
Carstens J; Andersen HK; Spencer E; Madsen M
Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
[TBL] [Abstract][Full Text] [Related]
5. Role of antigenemia assay in the early diagnosis and treatment of CMV infection in renal transplant patients.
Chiaramonte S; Pellizzer G; Rassu M; Dissegna D; Bragantiini L; Zuccarotto D; La Greca G
Clin Nephrol; 2000 Apr; 53(4):suppl 10-2. PubMed ID: 10809428
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
[TBL] [Abstract][Full Text] [Related]
8. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
Murray BM; Subramaniam S
Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
[TBL] [Abstract][Full Text] [Related]
9. Prevention of CMV disease in pediatric kidney transplant recipients: evaluation of pp67 NASBA-based pre-emptive ganciclovir therapy combined with CMV hyperimmune globulin prophylaxis in high-risk patients.
Renoult E; Clermont MJ; Phan V; Buteau C; Alfieri C; Tapiero B
Pediatr Transplant; 2008 Jun; 12(4):420-5. PubMed ID: 18466427
[TBL] [Abstract][Full Text] [Related]
10. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
Boobes Y; Al Hakim M; Dastoor H; Bernieh B; Abdulkhalik S
Transplant Proc; 2004; 36(6):1841-3. PubMed ID: 15350493
[TBL] [Abstract][Full Text] [Related]
11. Acute infection of Toxoplasma gondii and cytomegalovirus reactivation in a pediatric patient receiving liver transplant.
Galván Ramírez ML; Castillo-de-León Y; Espinoza-Oliva M; Bojorques-Ramos MC; Rodríguez-Pérez LR; Bernal Redondo R; Cañedo-Solares I; Espinoza López L; Correa D
Transpl Infect Dis; 2006 Dec; 8(4):233-6. PubMed ID: 17116139
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of cytomegalovirus infection following heart transplantation].
Laske A; Carrel T; Niederhäuser U; Bauer E; Pasic M; von Segesser LK; Gallino A; Turina M
Helv Chir Acta; 1992 Jan; 58(4):527-32. PubMed ID: 1316336
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection of the graft duodenum and urinary bladder after simultaneous pancreas-kidney transplantation.
Jang HJ; Kim SC; Cho YP; Kim YH; Han MS; Han DJ
Transplant Proc; 2004 Sep; 36(7):2200-2. PubMed ID: 15518799
[TBL] [Abstract][Full Text] [Related]
14. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
Shah T; Lai WK; Mutimer D
Transpl Infect Dis; 2005 Jun; 7(2):57-62. PubMed ID: 16150091
[TBL] [Abstract][Full Text] [Related]
15. Sequential cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies.
Ozaki KS; Pestana JO; Granato CF; Pacheco-Silva A; Camargo LF
Transpl Infect Dis; 2004 Jun; 6(2):63-8. PubMed ID: 15522106
[TBL] [Abstract][Full Text] [Related]
16. 24-week oral ganciclovir prophylaxis in kidney recipients is associated with reduced symptomatic cytomegalovirus disease compared to a 12-week course.
Doyle AM; Warburton KM; Goral S; Blumberg E; Grossman RA; Bloom RD
Transplantation; 2006 Apr; 81(8):1106-11. PubMed ID: 16641594
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus disease with atypical presentation in a renal transplant patient: case report.
Khosravi M; Nobakht A; Nikokar AR
Exp Clin Transplant; 2006 Jun; 4(1):458-61. PubMed ID: 16827643
[TBL] [Abstract][Full Text] [Related]
18. [Prospective study of cytomegalovirus infection in liver transplant recipients].
Lumbreras C; Otero JR; Aguado JM; Lizasoaín M; Gómez R; García I; Fuertes A; Colina F; Moreno E; Noriega AR
Med Clin (Barc); 1992 Oct; 99(11):401-5. PubMed ID: 1335102
[TBL] [Abstract][Full Text] [Related]
19. [Should recurrent Cytomegalovirus infections in patients with liver transplantation be treated?].
Tarp BD; Astrup LB
Ugeskr Laeger; 1997 May; 159(22):3413-6. PubMed ID: 9199030
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
